WallStreetZenWallStreetZen

NASDAQ: PLXP
Plx Pharma Inc Stock

$0.24+0.00 (+0%)
Updated Jan 27, 2023
PLXP Price
$0.24
Fair Value Price
$1.15
Market Cap
$7.02M
52 Week Low
$0.13
52 Week High
$6.66
P/E
-0.29x
P/B
0.69x
P/S
4.09x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.54M
Earnings
-$27.58M
Gross Margin
4.5%
Operating Margin
-610.3%
Profit Margin
-606.9%
Debt to Equity
0.69
Operating Cash Flow
-$59M
Beta
0.87
Next Earnings
Mar 9, 2023
Ex-Dividend
N/A
Next Dividend
N/A

PLXP Overview

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PLXP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PLXP ($0.24) is undervalued by 78.99% relative to our estimate of its Fair Value price of $1.15 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PLXP ($0.24) is significantly undervalued by 78.99% relative to our estimate of its Fair Value price of $1.15 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
PLXP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PLXP due diligence checks available for Premium users.

Be the first to know about important PLXP news, forecast changes, insider trades & much more!

PLXP News

Valuation

PLXP fair value

Fair Value of PLXP stock based on Discounted Cash Flow (DCF)
Price
$0.24
Fair Value
$1.15
Undervalued by
79.08%
PLXP ($0.24) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PLXP ($0.24) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PLXP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PLXP price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.29x
Industry
20.07x
Market
23.59x

PLXP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.69x
Industry
1.9x
PLXP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PLXP's financial health

Profit margin

Revenue
$386.0k
Net Income
-$8.5M
Profit Margin
-2,201.3%
PLXP's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PLXP's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$33.2M
Liabilities
$7.0M
Debt to equity
0.69
PLXP's short-term assets ($30.22M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PLXP's short-term assets ($30.22M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PLXP's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PLXP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$11.0M
Investing
$0.0
Financing
$1.1M
PLXP's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PLXP vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
PLXP$7.02M-1.23%-0.29x0.69x
SNOA$6.27M+4.66%-1.01x0.89x
PTPI$5.45M-2.23%-0.17x0.26x
PRFX$5.37M+1.20%-0.72x0.40x
CPHI$5.32M-1.90%-1.29x1.88x

Plx Pharma Stock FAQ

What is Plx Pharma's quote symbol?

NASDAQ: PLXP) Plx Pharma trades on the NASDAQ under the ticker symbol PLXP. Plx Pharma stock quotes can also be displayed as NASDAQ: PLXP.

If you're new to stock investing, here's how to buy Plx Pharma stock.

What is the 52 week high and low for Plx Pharma (NASDAQ: PLXP)?

(NASDAQ: PLXP) Plx Pharma's 52-week high was $6.66, and its 52-week low was $0.13. It is currently -96.38% from its 52-week high and 85.38% from its 52-week low.

How much is Plx Pharma stock worth today?

(NASDAQ: PLXP) Plx Pharma currently has 29,137,692 outstanding shares. With Plx Pharma stock trading at $0.24 per share, the total value of Plx Pharma stock (market capitalization) is $7.02M.

Plx Pharma stock was originally listed at a price of $112.32 in Mar 13, 2014. If you had invested in Plx Pharma stock at $112.32, your return over the last 8 years would have been -99.79%, for an annualized return of -53.61% (not including any dividends or dividend reinvestments).

How much is Plx Pharma's stock price per share?

(NASDAQ: PLXP) Plx Pharma stock price per share is $0.24 today (as of Jan 27, 2023).

What is Plx Pharma's Market Cap?

(NASDAQ: PLXP) Plx Pharma's market cap is $7.02M, as of Jan 29, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Plx Pharma's market cap is calculated by multiplying PLXP's current stock price of $0.24 by PLXP's total outstanding shares of 29,137,692.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.